The latter subtype also includes triple-negative breast cancer, which lacks immunohistochemical detection of estrogen receptor (ER), progesterone receptor (PR) and human epithelial growth factor receptor-2 (HER-2) [66]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.